Trial intelligence / Profile preview

Comparative Study of Mycosinate vs Curanail for Fungal Nail Infection

2018-000294-78Phase 2Terminated

Sponsor
Nektr Technologies
Start
Jul 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, single-blind trial in onychomycosis comparing Mycosinate arm with Curanail arm (2 arms). Primary endpoint: Viability of the infection. Started Jul 2018; status: terminated.

02

Drugs

Mycosinateamorolfine
03

Conditions

onychomycosis

Beyond the preview

Go deeper on 2018-000294-78.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2018-000294-78.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call